United States Biotechnology & Medical Research

Jade Biosciences Inc (JBIO)

Track

The most recent insider trading activity occurred on June 25, 2025, with significant proposed sales by Atlas Venture Fund XII, L.P. and Atlas Venture Associates XII, L.P. Earlier, on May 16, 2025, the CEO, Frohlich Tom, made a purchase. Prior to that, in June 2024, RA CAPITAL MANAGEMENT, L.P. executed a substantial buy, while several officers engaged in planned and proposed sales.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: JBIO Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Atlas Venture Fund XII, L.P.

Shareholder

1 sale — total 303,679 USD

Proposed sale 25 Jun 2025

Value US$618,360.89 | Price 473.68 | Shares 60,746

Atlas Venture Associates XII, L.P.

Shareholder

1 sale — total 2,463 USD

Proposed sale 25 Jun 2025

Value US$585,597.35 | Price 167.80 | Shares 57,098

Atlas Venture Fund XII, L.P.

Shareholder

1 sale — total 159,223 USD

Proposed sale 24 Jun 2025

Value US$159,222.84 | Price 9.87 | Shares 16,132

Atlas Venture Associates XII, L.P.

Shareholder

1 sale — total 1,293 USD

Proposed sale 24 Jun 2025

Value US$1,292.97 | Price 9.87 | Shares 131

Frohlich Tom

Chief Executive Officer

1 purchase — total 44,400 USD

Buy 16 May 2025

Value US$44,400.00 | Price 7.40 | Shares 6,000

Atlas Venture Associates XII, L.P.

Shareholder

1 sale — total 552 USD

Proposed sale 6 May 2025

Value US$552.00 | Price 11.50 | Shares 48

Atlas Venture Fund XII, L.P.

Shareholder

1 sale — total 67,655 USD

Proposed sale 6 May 2025

Value US$67,654.50 | Price 11.50 | Shares 5,883

RA CAPITAL MANAGEMENT, L.P.

1 purchase — total 1,549,944 USD

Buy 17 Jun 2024

Value US$1,549,943.70 | Price 1.67 | Shares 928,110

MARINUS VERWIJS

Officer

1 sale — total 265,000 USD

Proposed sale 14 Jun 2024

Value US$265,000.00 | Price 25.00 | Shares 10,600

Verwijs Marinus

CHIEF TECHNICAL OFFICER

1 sale — total 265,000 USD

Planned sale 14 Jun 2024

Value US$265,000.00 | Price 25.00 | Shares 10,600

Eldridge George A

SEE REMARKS

1 sale — total 375,450 USD

Planned sale 14 Jun 2024

Value US$375,450.00 | Price 25.03 | Shares 15,000

Gillies Hunter

CHIEF MEDICAL OFFICER

1 sale — total 147,000 USD

Planned sale 13 Jun 2024

Value US$147,000.00 | Price 24.50 | Shares 6,000

HUNTER C GILLIES

Officer

1 sale — total 147,000 USD

Proposed sale 13 Jun 2024

Value US$147,000.00 | Price 24.50 | Shares 6,000

HUNTER C GILLIES

Officer

1 sale — total 84,331 USD

Proposed sale 17 May 2024

Value US$84,331.20 | Price 21.08 | Shares 4,000

Gillies Hunter

CHIEF MEDICAL OFFICER

2 sales — total 84,332 USD

Planned sale 17 May 2024

Value US$1,879.96 | Price 21.86 | Shares 86

Planned sale 17 May 2024

Value US$82,451.54 | Price 21.07 | Shares 3,914

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

2 sales — total 215,755 USD

Planned sale 16 May 2024

Value US$28,345.15 | Price 21.92 | Shares 1,293

Planned sale 16 May 2024

Value US$187,410.34 | Price 21.52 | Shares 8,707

TIMOTHY NOYES

Officer; Director

1 sale — total 215,755 USD

Proposed sale 16 May 2024

Value US$215,755.00 | Price 21.58 | Shares 10,000

Verwijs Marinus

CHIEF TECHNICAL OFFICER

3 sales — total 124,892 USD

Planned sale 2 May 2024

Value US$41,630.72 | Price 21.02 | Shares 1,981

Planned sale 2 May 2024

Value US$41,630.72 | Price 21.02 | Shares 1,981

Proposed sale 2 May 2024

Value US$41,630.77 | Price 21.02 | Shares 1,981

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

3 sales — total 230,946 USD

Planned sale 1 May 2024

Value US$27,017.87 | Price 19.91 | Shares 1,357

Planned sale 1 May 2024

Value US$20,135.01 | Price 20.87 | Shares 965

Planned sale 1 May 2024

Value US$183,792.68 | Price 20.34 | Shares 9,035

TIMOTHY NOYES

Officer; Director

1 sale — total 230,945 USD

Proposed sale 1 May 2024

Value US$230,944.87 | Price 20.34 | Shares 11,357

Gillies Hunter

CHIEF MEDICAL OFFICER

2 sales — total 89,522 USD

Planned sale 17 Apr 2024

Value US$7,254.91 | Price 23.33 | Shares 311

Planned sale 17 Apr 2024

Value US$82,266.91 | Price 22.30 | Shares 3,689

Dake Benjamin T

SEE REMARKS

4 sales — total 315,195 USD

Planned sale 17 Apr 2024

Value US$1,629.96 | Price 23.97 | Shares 68

Planned sale 17 Apr 2024

Value US$7,831.43 | Price 23.17 | Shares 338

Planned sale 17 Apr 2024

Value US$143,865.45 | Price 22.32 | Shares 6,447

Proposed sale 17 Apr 2024

Value US$161,867.86 | Price 23.62 | Shares 6,853

HUNTER C GILLIES

Officer

1 sale — total 89,522 USD

Proposed sale 17 Apr 2024

Value US$89,521.60 | Price 22.38 | Shares 4,000

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

2 sales — total 246,971 USD

Planned sale 16 Apr 2024

Value US$137,409.89 | Price 24.94 | Shares 5,509

Planned sale 16 Apr 2024

Value US$109,560.64 | Price 24.40 | Shares 4,491

TIMOTHY NOYES

Officer; Director

1 sale — total 246,970 USD

Proposed sale 16 Apr 2024

Value US$246,970.00 | Price 24.70 | Shares 10,000

Eldridge George A

SEE REMARKS

2 sales — total 201,392 USD

Planned sale 10 Apr 2024

Value US$21,252.31 | Price 27.56 | Shares 771

Planned sale 10 Apr 2024

Value US$180,139.37 | Price 26.77 | Shares 6,729

GRAYZEL DAVID S.

1 sale — total 334,478 USD

Sale 9 Apr 2024

Value US$334,478.30 | Price 28.15 | Shares 11,882

Atlas Venture Associates XII, L.P.

Director

1 sale — total 314,635 USD

Proposed sale 9 Apr 2024

Value US$314,635.36 | Price 26.48 | Shares 11,882

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

4 sales — total 300,033 USD

Planned sale 1 Apr 2024

Value US$31,950.00 | Price 31.95 | Shares 1,000

Planned sale 1 Apr 2024

Value US$88,446.00 | Price 31.02 | Shares 2,851

Planned sale 1 Apr 2024

Value US$49,237.89 | Price 29.90 | Shares 1,647

Planned sale 1 Apr 2024

Value US$130,399.08 | Price 28.96 | Shares 4,502

Verwijs Marinus

CHIEF TECHNICAL OFFICER

2 sales — total 154,697 USD

Planned sale 1 Apr 2024

Value US$45,118.50 | Price 30.00 | Shares 1,504

Planned sale 1 Apr 2024

Value US$109,578.75 | Price 28.87 | Shares 3,796

Dake Benjamin T

SEE REMARKS

1 sale — total 106,317 USD

Planned sale 1 Apr 2024

Value US$106,316.54 | Price 31.97 | Shares 3,325

Eldridge George A

SEE REMARKS

2 sales — total 1,496,126 USD

Planned sale 1 Apr 2024

Value US$390,207.60 | Price 31.23 | Shares 12,495

Proposed sale 1 Apr 2024

Value US$1,105,918.00 | Price 29.57 | Shares 37,400

TIMOTHY NOYES

Officer; Director

1 sale — total 300,033 USD

Proposed sale 1 Apr 2024

Value US$300,033.00 | Price 30.00 | Shares 10,000

MARINUS VERWIJS

Officer

1 sale — total 154,697 USD

Proposed sale 1 Apr 2024

Value US$154,696.93 | Price 29.19 | Shares 5,300

Gillies Hunter

CHIEF MEDICAL OFFICER

1 sale — total 265,500 USD

Planned sale 28 Mar 2024

Value US$265,500.00 | Price 29.50 | Shares 9,000

HUNTER C GILLIES

Officer

1 sale — total 265,500 USD

Proposed sale 28 Mar 2024

Value US$265,500.00 | Price 29.50 | Shares 9,000

Dake Benjamin T

SEE REMARKS

1 sale — total 309,519 USD

Planned sale 27 Mar 2024

Value US$309,518.83 | Price 27.97 | Shares 11,068

Dake Benjamin T

SEE REMARKS

1 sale — total 96,119 USD

Planned sale 25 Mar 2024

Value US$96,119.34 | Price 28.01 | Shares 3,432

Verwijs Marinus

CHIEF TECHNICAL OFFICER

2 sales — total 138,243 USD

Planned sale 19 Mar 2024

Value US$73,123.83 | Price 26.46 | Shares 2,764

Planned sale 19 Mar 2024

Value US$65,119.15 | Price 25.68 | Shares 2,536

MARINUS VERWIJS

Officer

1 sale — total 138,243 USD

Proposed sale 19 Mar 2024

Value US$138,242.55 | Price 26.08 | Shares 5,300

Dake Benjamin T

SEE REMARKS

3 sales — total 2,414,193 USD

Planned sale 18 Mar 2024

Value US$200,763.83 | Price 26.48 | Shares 7,581

Planned sale 18 Mar 2024

Value US$707,281.70 | Price 25.74 | Shares 27,476

Proposed sale 18 Mar 2024

Value US$1,506,147.00 | Price 26.70 | Shares 56,410

Gillies Hunter

CHIEF MEDICAL OFFICER

2 sales — total 181,057 USD

Planned sale 18 Mar 2024

Value US$16,184.55 | Price 26.40 | Shares 613

Planned sale 18 Mar 2024

Value US$164,872.10 | Price 25.81 | Shares 6,387

HUNTER C GILLIES

Officer

1 sale — total 181,056 USD

Proposed sale 18 Mar 2024

Value US$181,056.20 | Price 25.87 | Shares 7,000

Eldridge George A

SEE REMARKS

1 sale — total 50,445 USD

Planned sale 13 Mar 2024

Value US$50,444.96 | Price 25.02 | Shares 2,016

Eldridge George A

SEE REMARKS

1 sale — total 51,370 USD

Planned sale 12 Mar 2024

Value US$51,369.55 | Price 25.05 | Shares 2,051

Eldridge George A

SEE REMARKS

2 sales — total 86,667 USD

Planned sale 11 Mar 2024

Value US$263.05 | Price 26.31 | Shares 10

Planned sale 11 Mar 2024

Value US$86,404.39 | Price 25.24 | Shares 3,423

Eldridge George A

SEE REMARKS

1 sale — total 2,850 USD

Planned sale 8 Mar 2024

Value US$2,850.00 | Price 25.00 | Shares 114

Eldridge George A

SEE REMARKS

2 sales — total 1,275,788 USD

Planned sale 7 Mar 2024

Value US$559,688.06 | Price 25.00 | Shares 22,386

Proposed sale 7 Mar 2024

Value US$716,100.00 | Price 23.87 | Shares 30,000

Gillies Hunter

CHIEF MEDICAL OFFICER

1 sale — total 219,888 USD

Planned sale 7 Mar 2024

Value US$219,887.50 | Price 24.50 | Shares 8,975

HUNTER C GILLIES

Officer

1 sale — total 219,888 USD

Proposed sale 7 Mar 2024

Value US$219,887.50 | Price 24.50 | Shares 8,975

Gillies Hunter

CHIEF MEDICAL OFFICER

1 sale — total 9,965 USD

Planned sale 23 Feb 2024

Value US$9,964.50 | Price 19.50 | Shares 511

HUNTER C GILLIES

Officer

1 sale — total 9,965 USD

Proposed sale 23 Feb 2024

Value US$9,964.50 | Price 19.50 | Shares 511

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-06-25	2025-06-25	PrS Proposed sale	Atlas Venture Fund XII, L.P. Shareholder	60,746 473.68 US$618,361	60,746	473.68	US$618,361
2025-06-25	2025-06-25	PrS Proposed sale	Atlas Venture Associates XII, L.P. Shareholder	57,098 167.80 US$585,597	57,098	167.80	US$585,597
2025-06-24	2025-06-24	PrS Proposed sale	Atlas Venture Fund XII, L.P. Shareholder	6,869 315.21 US$2,805,274	6,869	315.21	US$2,805,274
2025-06-24	2025-06-24	PrS Proposed sale	Atlas Venture Associates XII, L.P. Shareholder	131 9.87 US$1,293	131	9.87	US$1,293
2025-05-19	2025-05-16	B Purchase	0.9 Frohlich Tom Chief Executive Officer Executive Director	6,000 +inf% 7.40 US$44,400	6,000 +inf%	7.40	US$44,400
2025-05-06	2025-05-06	PrS Proposed sale	Atlas Venture Associates XII, L.P. Shareholder	48 11.50 US$552	48	11.50	US$552
2025-05-06	2025-05-06	PrS Proposed sale	Atlas Venture Fund XII, L.P. Shareholder	5,883 11.50 US$67,654	5,883	11.50	US$67,654
2024-06-20	2024-06-17	B Purchase	2.9 RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder	928,110 +13.3% 1.67 US$1,549,944	928,110 +13.3%	1.67	US$1,549,944
2024-06-14	2024-06-14	PrS Proposed sale	MARINUS VERWIJS Officer Officer	10,600 25.00 US$265,000	10,600	25.00	US$265,000
2024-06-14	2024-06-14	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	10,600 -100.0% 25.00 US$265,000	10,600 -100.0%	25.00	US$265,000
2024-06-14	2024-06-14	PlS Planned sale	Eldridge George A SEE REMARKS Officer	15,000 -74.9% 25.03 US$375,450	15,000 -74.9%	25.03	US$375,450
2024-06-14	2024-06-13	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	6,000 -51.7% 24.50 US$147,000	6,000 -51.7%	24.50	US$147,000
2024-06-13	2024-06-13	PrS Proposed sale	HUNTER C GILLIES Officer Officer	6,000 24.50 US$147,000	6,000	24.50	US$147,000
2024-05-17	2024-05-17	PrS Proposed sale	HUNTER C GILLIES Officer Officer	4,000 21.08 US$84,331	4,000	21.08	US$84,331
2024-05-17	2024-05-17	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	86 -1.5% 21.86 US$1,880	86 -1.5%	21.86	US$1,880
2024-05-17	2024-05-17	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	3,914 -40.8% 21.07 US$82,452	3,914 -40.8%	21.07	US$82,452
2024-05-17	2024-05-16	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	1,293 -100.0% 21.92 US$28,345	1,293 -100.0%	21.92	US$28,345
2024-05-17	2024-05-16	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	8,707 -87.1% 21.52 US$187,410	8,707 -87.1%	21.52	US$187,410
2024-05-16	2024-05-16	PrS Proposed sale	TIMOTHY NOYES Officer; Director Executive Director	10,000 21.58 US$215,755	10,000	21.58	US$215,755
2024-05-03	2024-05-02	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	1,981 -100.0% 21.02 US$41,631	1,981 -100.0%	21.02	US$41,631
2024-05-03	2024-05-02	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	1,981 -100.0% 21.02 US$41,631	1,981 -100.0%	21.02	US$41,631
2024-05-02	2024-05-02	PrS Proposed sale	Verwijs Marinus Officer Officer	1,981 21.02 US$41,631	1,981	21.02	US$41,631
2024-05-03	2024-05-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	1,357 -100.0% 19.91 US$27,018	1,357 -100.0%	19.91	US$27,018
2024-05-03	2024-05-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	965 -100.0% 20.87 US$20,135	965 -100.0%	20.87	US$20,135
2024-05-03	2024-05-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	9,035 -90.3% 20.34 US$183,793	9,035 -90.3%	20.34	US$183,793
2024-05-01	2024-05-01	PrS Proposed sale	TIMOTHY NOYES Officer; Director Executive Director	11,357 20.34 US$230,945	11,357	20.34	US$230,945
2024-04-19	2024-04-17	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	311 -8.7% 23.33 US$7,255	311 -8.7%	23.33	US$7,255
2024-04-19	2024-04-17	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	3,689 -50.9% 22.30 US$82,267	3,689 -50.9%	22.30	US$82,267
2024-04-19	2024-04-17	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	68 -5.0% 23.97 US$1,630	68 -5.0%	23.97	US$1,630
2024-04-19	2024-04-17	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	338 -19.9% 23.17 US$7,831	338 -19.9%	23.17	US$7,831
2024-04-19	2024-04-17	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	6,447 -79.2% 22.32 US$143,865	6,447 -79.2%	22.32	US$143,865
2024-04-17	2024-04-17	PrS Proposed sale	Dake Benjamin T Officer Officer	6,853 23.62 US$161,868	6,853	23.62	US$161,868
2024-04-17	2024-04-17	PrS Proposed sale	HUNTER C GILLIES Officer Officer	4,000 22.38 US$89,522	4,000	22.38	US$89,522
2024-04-18	2024-04-16	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	5,509 -100.0% 24.94 US$137,410	5,509 -100.0%	24.94	US$137,410
2024-04-18	2024-04-16	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	4,491 -44.9% 24.40 US$109,561	4,491 -44.9%	24.40	US$109,561
2024-04-16	2024-04-16	PrS Proposed sale	TIMOTHY NOYES Officer; Director Executive Director	10,000 24.70 US$246,970	10,000	24.70	US$246,970
2024-04-12	2024-04-10	PlS Planned sale	Eldridge George A SEE REMARKS Officer	771 -28.2% 27.56 US$21,252	771 -28.2%	27.56	US$21,252
2024-04-12	2024-04-10	PlS Planned sale	Eldridge George A SEE REMARKS Officer	6,729 -71.1% 26.77 US$180,139	6,729 -71.1%	26.77	US$180,139
2024-04-11	2024-04-09	S Sale	3.4 GRAYZEL DAVID S. Non-Executive Director	11,882 -45.0% 28.15 US$334,478	11,882 -45.0%	28.15	US$334,478
2024-04-09	2024-04-09	PrS Proposed sale	Atlas Venture Associates XII, L.P. Director Non-Executive Director	11,882 26.48 US$314,635	11,882	26.48	US$314,635
2024-04-03	2024-04-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	1,000 -100.0% 31.95 US$31,950	1,000 -100.0%	31.95	US$31,950
2024-04-03	2024-04-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	2,851 -74.0% 31.02 US$88,446	2,851 -74.0%	31.02	US$88,446
2024-04-03	2024-04-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	1,647 -30.0% 29.90 US$49,238	1,647 -30.0%	29.90	US$49,238
2024-04-03	2024-04-01	PlS Planned sale	NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Executive Director	4,502 -45.0% 28.96 US$130,399	4,502 -45.0%	28.96	US$130,399
2024-04-03	2024-04-01	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	1,504 -100.0% 30.00 US$45,118	1,504 -100.0%	30.00	US$45,118
2024-04-03	2024-04-01	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	3,796 -71.6% 28.87 US$109,579	3,796 -71.6%	28.87	US$109,579
2024-04-03	2024-04-01	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	3,325 -72.0% 31.97 US$106,317	3,325 -72.0%	31.97	US$106,317
2024-04-03	2024-04-01	PlS Planned sale	Eldridge George A SEE REMARKS Officer	12,495 -86.4% 31.23 US$390,208	12,495 -86.4%	31.23	US$390,208
2024-04-01	2024-04-01	PrS Proposed sale	Eldridge George A Officer Officer	37,400 29.57 US$1,105,918	37,400	29.57	US$1,105,918
2024-04-01	2024-04-01	PrS Proposed sale	TIMOTHY NOYES Officer; Director Executive Director	10,000 30.00 US$300,033	10,000	30.00	US$300,033
2024-04-01	2024-04-01	PrS Proposed sale	MARINUS VERWIJS Officer Officer	5,300 29.19 US$154,697	5,300	29.19	US$154,697
2024-04-01	2024-03-28	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	9,000 -73.5% 29.50 US$265,500	9,000 -73.5%	29.50	US$265,500
2024-03-28	2024-03-28	PrS Proposed sale	HUNTER C GILLIES Officer Officer	9,000 29.50 US$265,500	9,000	29.50	US$265,500
2024-03-28	2024-03-27	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	11,068 -89.6% 27.97 US$309,519	11,068 -89.6%	27.97	US$309,519
2024-03-27	2024-03-25	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	3,432 -72.7% 28.01 US$96,119	3,432 -72.7%	28.01	US$96,119
2024-03-20	2024-03-19	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	2,764 -100.0% 26.46 US$73,124	2,764 -100.0%	26.46	US$73,124
2024-03-20	2024-03-19	PlS Planned sale	Verwijs Marinus CHIEF TECHNICAL OFFICER Officer	2,536 -47.8% 25.68 US$65,119	2,536 -47.8%	25.68	US$65,119
2024-03-19	2024-03-19	PrS Proposed sale	MARINUS VERWIJS Officer Officer	5,300 26.08 US$138,243	5,300	26.08	US$138,243
2024-03-20	2024-03-18	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	7,581 -85.4% 26.48 US$200,764	7,581 -85.4%	26.48	US$200,764
2024-03-20	2024-03-18	PlS Planned sale	Dake Benjamin T SEE REMARKS Officer	27,476 -75.6% 25.74 US$707,282	27,476 -75.6%	25.74	US$707,282
2024-03-20	2024-03-18	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	613 -15.9% 26.40 US$16,185	613 -15.9%	26.40	US$16,185
2024-03-20	2024-03-18	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	6,387 -62.3% 25.81 US$164,872	6,387 -62.3%	25.81	US$164,872
2024-03-18	2024-03-18	PrS Proposed sale	Dake Benjamin T Officer Officer	56,410 26.70 US$1,506,147	56,410	26.70	US$1,506,147
2024-03-18	2024-03-18	PrS Proposed sale	HUNTER C GILLIES Officer Officer	7,000 25.87 US$181,056	7,000	25.87	US$181,056
2024-03-14	2024-03-13	PlS Planned sale	Eldridge George A SEE REMARKS Officer	2,016 -50.7% 25.02 US$50,445	2,016 -50.7%	25.02	US$50,445
2024-03-14	2024-03-12	PlS Planned sale	Eldridge George A SEE REMARKS Officer	2,051 -51.1% 25.05 US$51,370	2,051 -51.1%	25.05	US$51,370
2024-03-11	2024-03-11	PlS Planned sale	Eldridge George A SEE REMARKS Officer	10 -0.5% 26.31 US$263	10 -0.5%	26.31	US$263
2024-03-11	2024-03-11	PlS Planned sale	Eldridge George A SEE REMARKS Officer	3,423 -63.5% 25.24 US$86,404	3,423 -63.5%	25.24	US$86,404
2024-03-11	2024-03-08	PlS Planned sale	Eldridge George A SEE REMARKS Officer	114 -5.5% 25.00 US$2,850	114 -5.5%	25.00	US$2,850
2024-03-11	2024-03-07	PlS Planned sale	Eldridge George A SEE REMARKS Officer	22,386 -91.9% 25.00 US$559,688	22,386 -91.9%	25.00	US$559,688
2024-03-11	2024-03-07	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	8,975 -73.4% 24.50 US$219,888	8,975 -73.4%	24.50	US$219,888
2024-03-07	2024-03-07	PrS Proposed sale	Eldridge George A Officer Officer	30,000 23.87 US$716,100	30,000	23.87	US$716,100
2024-03-07	2024-03-07	PrS Proposed sale	HUNTER C GILLIES Officer Officer	8,975 24.50 US$219,888	8,975	24.50	US$219,888
2024-02-27	2024-02-23	PlS Planned sale	Gillies Hunter CHIEF MEDICAL OFFICER Officer	511 -13.6% 19.50 US$9,964	511 -13.6%	19.50	US$9,964
2024-02-23	2024-02-23	PrS Proposed sale	HUNTER C GILLIES Officer Officer	511 19.50 US$9,964	511	19.50	US$9,964

Explore more

More insider trading research around Jade Biosciences Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Jade Biosciences Inc (JBIO)

Track

Featured in screeners

Stock chart

Transactions

Insider

Sort by

Trades

Explore more